back top
New ICRS Approved Course

1300 members from 70 countries Join ICRS

New ICRS Approved Course

09/08/2016

We are pleased to announce that the following symposium organized by LifeNet as an ICRS approved Course.

The Regenerative Therapies: Advanced Allograft Solutions for Sports Medicine and Orthopedics will be held on October 28th 2016 in Munich at Arthrex Training Center. This symposium is organized by LifeNet Health Institute for Regenerative Medicine.

“The purpose of this meeting is to offer participants the opportunity to directly connect with highly respected providers and scientists from the fields of transformative therapies on technologies and tools in regenerative, reconstructive or restorative applications. 

Established in 2013, the LifeNet Health Institute of Regenerative Medicine hosts its annual scientific symposium for the purpose of inspiring an interactive dialogue among clinicians, administrators and allograft scientists. The symposium’s annual themes specifically focus on key topics within the field of regenerative medicine and allograft solutions for the purpose of inspiring and recognizing the deep appreciation for the scientific method of allograft sciences, thinking and dreaming of the possibilities for allografts and improved patient care overall”

Unlike the major conferences, the LifeNet Health Institute of Regenerative Medicine prides itself on being able to provide vast educational opportunities in a venue that truly fosters education, interaction, discovery and collaboration.  Our model allows speakers and participants to connect in a unique “unplugged” setting.  Attendees have historically been comprised of representatives from biotech companies, educational institutions, research facilities, and other health care establishments from around the US and internationally. This year, we add to this sports medicine and orthopedic surgeons from Europe.  In addition, past meetings have been endorsed by TERMIS, the Society for Biomaterials, and ICRS.”

Please visit meeting website for details.